Skip to main content
Rapid Reactions

Updates on 1L Maintenance Therapy with PARP Inhibitors for Advanced Ovarian Cancer

David O’Malley, MD
Director, Division of Gynecologic Oncology
James Cancer Hospital
The Ohio State University
Dr David M. O’Malley, Professor, Department of Obstetrics and Gynecology at The Ohio State University College of Medicine and Director of the Division of Gynecologic Oncology at the OSUCCC – James, discusses his perspectives on the current treatment landscape and optimal clinical management of patients with advanced ovarian cancer who are given PARP-is as maintenance therapy in the first-line setting.

Related Articles